These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 16904417

  • 21. Initiation and continuation rates seen in 2-year experience with Same Day injections of DMPA.
    Nelson AL, Katz T.
    Contraception; 2007 Feb; 75(2):84-7. PubMed ID: 17241834
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Same-day administration of depot-medroxyprogesterone acetate injection: a retrospective chart review.
    Balkus J, Miller L.
    Contraception; 2005 May; 71(5):395-8. PubMed ID: 15854642
    [Abstract] [Full Text] [Related]

  • 27. Interest in self-administration of subcutaneous depot medroxyprogesterone acetate in the United States.
    Upadhyay UD, Zlidar VM, Foster DG.
    Contraception; 2016 Oct; 94(4):303-13. PubMed ID: 27326938
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Self-administration of subcutaneous depot medroxyprogesterone acetate by adolescent women.
    Williams RL, Hensel DJ, Fortenberry JD.
    Contraception; 2013 Sep; 88(3):401-7. PubMed ID: 23294549
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in Malawi.
    Burke HM, Chen M, Buluzi M, Fuchs R, Wevill S, Venkatasubramanian L, Santo LD, Ngwira B.
    Glob Health Sci Pract; 2019 Mar 22; 7(1):54-65. PubMed ID: 30894394
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The role of training in effective simulated self-injection of subcutaneous depot medroxyprogesterone acetate: observations from a usability study.
    Kaplan I, Ross D, Hilton F, Morgenstern D, Wolter K.
    Contraception; 2016 Oct 22; 94(4):314-20. PubMed ID: 27241898
    [Abstract] [Full Text] [Related]

  • 37. Women's satisfaction, use, storage and disposal of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) during a randomized trial.
    Burke HM, Chen M, Buluzi M, Fuchs R, Wevill S, Venkatasubramanian L, Dal Santo L, Ngwira B.
    Contraception; 2018 Nov 22; 98(5):418-422. PubMed ID: 29758176
    [Abstract] [Full Text] [Related]

  • 38. Self-administration of subcutaneous depot medroxyprogesterone acetate for contraception: feasibility and acceptability.
    Prabhakaran S, Sweet A.
    Contraception; 2012 May 22; 85(5):453-7. PubMed ID: 22079605
    [Abstract] [Full Text] [Related]

  • 39. Transvaginal Doppler sonography for evaluation of irregular uterine bleeding with DMPA.
    Hussein M.
    Arch Gynecol Obstet; 2011 Jun 22; 283(6):1325-8. PubMed ID: 20582427
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.